79 related articles for article (PubMed ID: 18681831)
21. The antibody to plasminogen activator inhibitor-1 suppresses pulmonary metastases of human fibrosarcoma in athymic mice.
Tsuchiya H; Katsuo S; Matsuda E; Sunayama C; Tomita K; Ueda Y; Binder BR
Gen Diagn Pathol; 1995 May; 141(1):41-8. PubMed ID: 8542506
[TBL] [Abstract][Full Text] [Related]
22. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation.
Badier-Commander C; Verbeuren T; Lebard C; Michel JB; Jacob MP
J Pathol; 2000 Sep; 192(1):105-12. PubMed ID: 10951407
[TBL] [Abstract][Full Text] [Related]
23. Tissue inhibitor of metalloproteinases (TIMP)-1 creates a premetastatic niche in the liver through SDF-1/CXCR4-dependent neutrophil recruitment in mice.
Seubert B; Grünwald B; Kobuch J; Cui H; Schelter F; Schaten S; Siveke JT; Lim NH; Nagase H; Simonavicius N; Heikenwalder M; Reinheckel T; Sleeman JP; Janssen KP; Knolle PA; Krüger A
Hepatology; 2015 Jan; 61(1):238-48. PubMed ID: 25131778
[TBL] [Abstract][Full Text] [Related]
24. Soybean saponin inhibits tumor cell metastasis by modulating expressions of MMP-2, MMP-9 and TIMP- 2.
Kang JH; Han IH; Sung MK; Yoo H; Kim YG; Kim JS; Kawada T; Yu R
Cancer Lett; 2008 Mar; 261(1):84-92. PubMed ID: 18086515
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of invasion of HT1080 sarcoma cells expressing recombinant plasminogen activator inhibitor 2.
Laug WE; Cao XR; Yu YB; Shimada H; Kruithof EK
Cancer Res; 1993 Dec; 53(24):6051-7. PubMed ID: 8261421
[TBL] [Abstract][Full Text] [Related]
26. Transgenic TIMP-1 inhibits simian virus 40 T antigen-induced hepatocarcinogenesis by impairment of hepatocellular proliferation and tumor angiogenesis.
Martin DC; Sanchez-Sweatman OH; Ho AT; Inderdeo DS; Tsao MS; Khokha R
Lab Invest; 1999 Feb; 79(2):225-34. PubMed ID: 10068210
[TBL] [Abstract][Full Text] [Related]
27. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH
BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471
[TBL] [Abstract][Full Text] [Related]
28. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
[TBL] [Abstract][Full Text] [Related]
29. TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro.
Bigelow RL; Williams BJ; Carroll JL; Daves LK; Cardelli JA
Breast Cancer Res Treat; 2009 Sep; 117(1):31-44. PubMed ID: 18787947
[TBL] [Abstract][Full Text] [Related]
30. Mouse trophoblastic cell lines: II--Relationship between invasive potential and proteases.
Sharma RK
In Vivo; 1998; 12(2):209-17. PubMed ID: 9627804
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of metastasis in human gastric cancer cells transfected with tissue inhibitor of metalloproteinase 1 gene in nude mice.
Watanabe M; Takahashi Y; Ohta T; Mai M; Sasaki T; Seiki M
Cancer; 1996 Apr; 77(8 Suppl):1676-80. PubMed ID: 8608561
[TBL] [Abstract][Full Text] [Related]
32. Antisense oligonucleotide of tissue inhibitor of metalloproteinase-1 induces the plasminogen activator activity in periodontal ligament cells.
Shibata Y; Takiguchi H; Abiko Y
J Periodontol; 1999 Oct; 70(10):1158-65. PubMed ID: 10534069
[TBL] [Abstract][Full Text] [Related]
33. Tumor metastasis and the reciprocal regulation of prometastatic and antimetastatic factors by nuclear factor kappaB.
Andela VB; Schwarz EM; Puzas JE; O'Keefe RJ; Rosier RN
Cancer Res; 2000 Dec; 60(23):6557-62. PubMed ID: 11118032
[TBL] [Abstract][Full Text] [Related]
34. Loss of the metastatic phenotype by a human epidermoid carcinoma cell line, HEp-3, is accompanied by increased expression of tissue inhibitor of metalloproteinase 2.
Testa JE
Cancer Res; 1992 Oct; 52(20):5597-603. PubMed ID: 1327511
[TBL] [Abstract][Full Text] [Related]
35. Expression of matrix metalloproteinases, their inhibitors, and urokinase plasminogen activator in human meningiomas.
Siddique K; Yanamandra N; Gujrati M; Dinh D; Rao JS; Olivero W
Int J Oncol; 2003 Feb; 22(2):289-94. PubMed ID: 12527924
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effects of a benz[f]indole-4,9-dione analog on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
Park HJ; Lee HJ; Min HY; Chung HJ; Suh ME; Park-Choo HY; Kim C; Kim HJ; Seo EK; Lee SK
Eur J Pharmacol; 2005 Dec; 527(1-3):31-6. PubMed ID: 16309669
[TBL] [Abstract][Full Text] [Related]
37. Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells from extrinsic cell death: a potential oncogenic activity of tissue inhibitor of metalloproteinase-1.
Liu XW; Taube ME; Jung KK; Dong Z; Lee YJ; Roshy S; Sloane BF; Fridman R; Kim HR
Cancer Res; 2005 Feb; 65(3):898-906. PubMed ID: 15705888
[TBL] [Abstract][Full Text] [Related]
38. Suppression of plasminogen activators and the MMP-2/-9 pathway by a Zanthoxylum avicennae extract to inhibit the HA22T human hepatocellular carcinoma cell migration and invasion effects in vitro and in vivo via phosphatase 2A activation.
Dung TD; Feng CC; Kuo WW; Pai P; Chung LC; Chang SH; Hsu HH; Tsai FJ; Lin YM; Huang CY
Biosci Biotechnol Biochem; 2013; 77(9):1814-21. PubMed ID: 24018669
[TBL] [Abstract][Full Text] [Related]
39. Expression and localisation of extracellular matrix degrading proteases and their inhibitors during the oestrous cycle and after induced luteolysis in the bovine corpus luteum.
Kliem H; Welter H; Kraetzl WD; Steffl M; Meyer HH; Schams D; Berisha B
Reproduction; 2007 Sep; 134(3):535-47. PubMed ID: 17709571
[TBL] [Abstract][Full Text] [Related]
40. Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model.
Soff GA; Sanderowitz J; Gately S; Verrusio E; Weiss I; Brem S; Kwaan HC
J Clin Invest; 1995 Dec; 96(6):2593-600. PubMed ID: 8675623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
